nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—bone cancer	0.386	0.756	CbGaD
Clomipramine—GSTP1—Carboplatin—bone cancer	0.179	0.474	CbGbCtD
Clomipramine—GSTP1—Cisplatin—bone cancer	0.153	0.405	CbGbCtD
Clomipramine—CYP3A4—bone cancer	0.125	0.244	CbGaD
Clomipramine—ALB—Methotrexate—bone cancer	0.0124	0.0329	CbGbCtD
Clomipramine—ABCB1—Cisplatin—bone cancer	0.00999	0.0265	CbGbCtD
Clomipramine—ABCB1—Doxorubicin—bone cancer	0.00669	0.0177	CbGbCtD
Clomipramine—ABCB1—Methotrexate—bone cancer	0.00649	0.0172	CbGbCtD
Clomipramine—CYP2D6—Doxorubicin—bone cancer	0.00631	0.0167	CbGbCtD
Clomipramine—CYP3A4—Doxorubicin—bone cancer	0.00401	0.0106	CbGbCtD
Clomipramine—Olopatadine—CYP3A4—bone cancer	0.000215	0.108	CrCbGaD
Clomipramine—Alimemazine—CYP3A4—bone cancer	0.000196	0.0987	CrCbGaD
Clomipramine—Carbinoxamine—CYP3A4—bone cancer	0.000149	0.0748	CrCbGaD
Clomipramine—Chlorphenamine—CYP3A4—bone cancer	0.000127	0.0636	CrCbGaD
Clomipramine—Pipotiazine—CYP3A4—bone cancer	0.00012	0.0604	CrCbGaD
Clomipramine—Clobazam—CYP3A4—bone cancer	0.00012	0.0604	CrCbGaD
Clomipramine—Prochlorperazine—CYP3A4—bone cancer	0.000115	0.0578	CrCbGaD
Clomipramine—Adinazolam—CYP3A4—bone cancer	9.8e-05	0.0493	CrCbGaD
Clomipramine—Nortriptyline—CYP3A4—bone cancer	9.29e-05	0.0467	CrCbGaD
Clomipramine—Weight decreased—Doxorubicin—bone cancer	9.09e-05	0.001	CcSEcCtD
Clomipramine—Sinusitis—Epirubicin—bone cancer	9.09e-05	0.001	CcSEcCtD
Clomipramine—Hyperglycaemia—Doxorubicin—bone cancer	9.07e-05	0.000999	CcSEcCtD
Clomipramine—Agranulocytosis—Epirubicin—bone cancer	9.04e-05	0.000996	CcSEcCtD
Clomipramine—Pneumonia—Doxorubicin—bone cancer	9.01e-05	0.000994	CcSEcCtD
Clomipramine—Drowsiness—Doxorubicin—bone cancer	8.96e-05	0.000988	CcSEcCtD
Clomipramine—Visual impairment—Methotrexate—bone cancer	8.95e-05	0.000987	CcSEcCtD
Clomipramine—Hypersensitivity—Cisplatin—bone cancer	8.86e-05	0.000977	CcSEcCtD
Clomipramine—Bradycardia—Epirubicin—bone cancer	8.85e-05	0.000976	CcSEcCtD
Clomipramine—Flurazepam—CYP3A4—bone cancer	8.84e-05	0.0444	CrCbGaD
Clomipramine—Neuropathy peripheral—Doxorubicin—bone cancer	8.78e-05	0.000968	CcSEcCtD
Clomipramine—Trimipramine—CYP3A4—bone cancer	8.75e-05	0.044	CrCbGaD
Clomipramine—Jaundice—Doxorubicin—bone cancer	8.73e-05	0.000963	CcSEcCtD
Clomipramine—Rhinitis—Epirubicin—bone cancer	8.72e-05	0.000961	CcSEcCtD
Clomipramine—Urinary tract infection—Doxorubicin—bone cancer	8.71e-05	0.00096	CcSEcCtD
Clomipramine—Conjunctivitis—Doxorubicin—bone cancer	8.71e-05	0.00096	CcSEcCtD
Clomipramine—Hepatitis—Epirubicin—bone cancer	8.69e-05	0.000958	CcSEcCtD
Clomipramine—Eye disorder—Methotrexate—bone cancer	8.68e-05	0.000957	CcSEcCtD
Clomipramine—Tinnitus—Methotrexate—bone cancer	8.66e-05	0.000955	CcSEcCtD
Clomipramine—Hypoaesthesia—Epirubicin—bone cancer	8.65e-05	0.000954	CcSEcCtD
Clomipramine—Asthenia—Cisplatin—bone cancer	8.63e-05	0.000951	CcSEcCtD
Clomipramine—Pharyngitis—Epirubicin—bone cancer	8.63e-05	0.000951	CcSEcCtD
Clomipramine—Cardiac disorder—Methotrexate—bone cancer	8.62e-05	0.00095	CcSEcCtD
Clomipramine—Sweating—Doxorubicin—bone cancer	8.59e-05	0.000947	CcSEcCtD
Clomipramine—Urinary tract disorder—Epirubicin—bone cancer	8.59e-05	0.000947	CcSEcCtD
Clomipramine—Haematuria—Doxorubicin—bone cancer	8.54e-05	0.000942	CcSEcCtD
Clomipramine—Connective tissue disorder—Epirubicin—bone cancer	8.54e-05	0.000942	CcSEcCtD
Clomipramine—Urethral disorder—Epirubicin—bone cancer	8.52e-05	0.00094	CcSEcCtD
Clomipramine—Hepatobiliary disease—Doxorubicin—bone cancer	8.47e-05	0.000934	CcSEcCtD
Clomipramine—Epistaxis—Doxorubicin—bone cancer	8.45e-05	0.000932	CcSEcCtD
Clomipramine—Angiopathy—Methotrexate—bone cancer	8.43e-05	0.000929	CcSEcCtD
Clomipramine—Sinusitis—Doxorubicin—bone cancer	8.41e-05	0.000927	CcSEcCtD
Clomipramine—Immune system disorder—Methotrexate—bone cancer	8.39e-05	0.000925	CcSEcCtD
Clomipramine—Visual impairment—Epirubicin—bone cancer	8.38e-05	0.000924	CcSEcCtD
Clomipramine—Mediastinal disorder—Methotrexate—bone cancer	8.37e-05	0.000923	CcSEcCtD
Clomipramine—Agranulocytosis—Doxorubicin—bone cancer	8.36e-05	0.000922	CcSEcCtD
Clomipramine—Chills—Methotrexate—bone cancer	8.34e-05	0.000919	CcSEcCtD
Clomipramine—Doxepin—CYP3A4—bone cancer	8.33e-05	0.0419	CrCbGaD
Clomipramine—Diarrhoea—Cisplatin—bone cancer	8.23e-05	0.000907	CcSEcCtD
Clomipramine—Perphenazine—CYP3A4—bone cancer	8.22e-05	0.0413	CrCbGaD
Clomipramine—Alopecia—Methotrexate—bone cancer	8.21e-05	0.000905	CcSEcCtD
Clomipramine—Bradycardia—Doxorubicin—bone cancer	8.19e-05	0.000903	CcSEcCtD
Clomipramine—Mental disorder—Methotrexate—bone cancer	8.14e-05	0.000897	CcSEcCtD
Clomipramine—Eye disorder—Epirubicin—bone cancer	8.12e-05	0.000896	CcSEcCtD
Clomipramine—Tinnitus—Epirubicin—bone cancer	8.11e-05	0.000894	CcSEcCtD
Clomipramine—Malnutrition—Methotrexate—bone cancer	8.09e-05	0.000892	CcSEcCtD
Clomipramine—Flushing—Epirubicin—bone cancer	8.07e-05	0.00089	CcSEcCtD
Clomipramine—Cardiac disorder—Epirubicin—bone cancer	8.07e-05	0.00089	CcSEcCtD
Clomipramine—Rhinitis—Doxorubicin—bone cancer	8.06e-05	0.000889	CcSEcCtD
Clomipramine—Hepatitis—Doxorubicin—bone cancer	8.04e-05	0.000887	CcSEcCtD
Clomipramine—Hypoaesthesia—Doxorubicin—bone cancer	8e-05	0.000882	CcSEcCtD
Clomipramine—Pharyngitis—Doxorubicin—bone cancer	7.98e-05	0.00088	CcSEcCtD
Clomipramine—Urinary tract disorder—Doxorubicin—bone cancer	7.94e-05	0.000876	CcSEcCtD
Clomipramine—Dysgeusia—Methotrexate—bone cancer	7.92e-05	0.000873	CcSEcCtD
Clomipramine—Connective tissue disorder—Doxorubicin—bone cancer	7.91e-05	0.000871	CcSEcCtD
Clomipramine—Angiopathy—Epirubicin—bone cancer	7.89e-05	0.00087	CcSEcCtD
Clomipramine—Urethral disorder—Doxorubicin—bone cancer	7.89e-05	0.000869	CcSEcCtD
Clomipramine—Immune system disorder—Epirubicin—bone cancer	7.85e-05	0.000866	CcSEcCtD
Clomipramine—Mediastinal disorder—Epirubicin—bone cancer	7.84e-05	0.000864	CcSEcCtD
Clomipramine—Back pain—Methotrexate—bone cancer	7.82e-05	0.000862	CcSEcCtD
Clomipramine—Chills—Epirubicin—bone cancer	7.8e-05	0.00086	CcSEcCtD
Clomipramine—Arrhythmia—Epirubicin—bone cancer	7.77e-05	0.000856	CcSEcCtD
Clomipramine—Visual impairment—Doxorubicin—bone cancer	7.75e-05	0.000855	CcSEcCtD
Clomipramine—Alopecia—Epirubicin—bone cancer	7.68e-05	0.000847	CcSEcCtD
Clomipramine—Vomiting—Cisplatin—bone cancer	7.65e-05	0.000843	CcSEcCtD
Clomipramine—Desipramine—CYP3A4—bone cancer	7.65e-05	0.0384	CrCbGaD
Clomipramine—Vision blurred—Methotrexate—bone cancer	7.62e-05	0.00084	CcSEcCtD
Clomipramine—Mental disorder—Epirubicin—bone cancer	7.62e-05	0.00084	CcSEcCtD
Clomipramine—Rash—Cisplatin—bone cancer	7.58e-05	0.000836	CcSEcCtD
Clomipramine—Dermatitis—Cisplatin—bone cancer	7.58e-05	0.000835	CcSEcCtD
Clomipramine—Malnutrition—Epirubicin—bone cancer	7.57e-05	0.000834	CcSEcCtD
Clomipramine—Eye disorder—Doxorubicin—bone cancer	7.52e-05	0.000829	CcSEcCtD
Clomipramine—Ill-defined disorder—Methotrexate—bone cancer	7.5e-05	0.000827	CcSEcCtD
Clomipramine—Tinnitus—Doxorubicin—bone cancer	7.5e-05	0.000827	CcSEcCtD
Clomipramine—Anaemia—Methotrexate—bone cancer	7.47e-05	0.000824	CcSEcCtD
Clomipramine—Cardiac disorder—Doxorubicin—bone cancer	7.47e-05	0.000823	CcSEcCtD
Clomipramine—Flushing—Doxorubicin—bone cancer	7.47e-05	0.000823	CcSEcCtD
Clomipramine—Flatulence—Epirubicin—bone cancer	7.46e-05	0.000822	CcSEcCtD
Clomipramine—Tension—Epirubicin—bone cancer	7.43e-05	0.000819	CcSEcCtD
Clomipramine—Dysgeusia—Epirubicin—bone cancer	7.41e-05	0.000817	CcSEcCtD
Clomipramine—Promazine—CYP3A4—bone cancer	7.41e-05	0.0372	CrCbGaD
Clomipramine—Nervousness—Epirubicin—bone cancer	7.35e-05	0.00081	CcSEcCtD
Clomipramine—Back pain—Epirubicin—bone cancer	7.32e-05	0.000807	CcSEcCtD
Clomipramine—Angiopathy—Doxorubicin—bone cancer	7.3e-05	0.000805	CcSEcCtD
Clomipramine—Malaise—Methotrexate—bone cancer	7.29e-05	0.000804	CcSEcCtD
Clomipramine—Muscle spasms—Epirubicin—bone cancer	7.28e-05	0.000802	CcSEcCtD
Clomipramine—Immune system disorder—Doxorubicin—bone cancer	7.27e-05	0.000801	CcSEcCtD
Clomipramine—Vertigo—Methotrexate—bone cancer	7.27e-05	0.000801	CcSEcCtD
Clomipramine—Mediastinal disorder—Doxorubicin—bone cancer	7.25e-05	0.000799	CcSEcCtD
Clomipramine—Leukopenia—Methotrexate—bone cancer	7.24e-05	0.000798	CcSEcCtD
Clomipramine—Chills—Doxorubicin—bone cancer	7.22e-05	0.000796	CcSEcCtD
Clomipramine—Arrhythmia—Doxorubicin—bone cancer	7.19e-05	0.000792	CcSEcCtD
Clomipramine—Nausea—Cisplatin—bone cancer	7.14e-05	0.000788	CcSEcCtD
Clomipramine—Vision blurred—Epirubicin—bone cancer	7.13e-05	0.000786	CcSEcCtD
Clomipramine—Alopecia—Doxorubicin—bone cancer	7.11e-05	0.000784	CcSEcCtD
Clomipramine—Cough—Methotrexate—bone cancer	7.06e-05	0.000778	CcSEcCtD
Clomipramine—Mental disorder—Doxorubicin—bone cancer	7.05e-05	0.000777	CcSEcCtD
Clomipramine—Ill-defined disorder—Epirubicin—bone cancer	7.02e-05	0.000774	CcSEcCtD
Clomipramine—Diazepam—CYP3A4—bone cancer	7.02e-05	0.0353	CrCbGaD
Clomipramine—Convulsion—Methotrexate—bone cancer	7.01e-05	0.000772	CcSEcCtD
Clomipramine—Malnutrition—Doxorubicin—bone cancer	7e-05	0.000772	CcSEcCtD
Clomipramine—Anaemia—Epirubicin—bone cancer	7e-05	0.000771	CcSEcCtD
Clomipramine—Agitation—Epirubicin—bone cancer	6.96e-05	0.000767	CcSEcCtD
Clomipramine—Flatulence—Doxorubicin—bone cancer	6.9e-05	0.000761	CcSEcCtD
Clomipramine—Arthralgia—Methotrexate—bone cancer	6.89e-05	0.000759	CcSEcCtD
Clomipramine—Chest pain—Methotrexate—bone cancer	6.89e-05	0.000759	CcSEcCtD
Clomipramine—Myalgia—Methotrexate—bone cancer	6.89e-05	0.000759	CcSEcCtD
Clomipramine—Tension—Doxorubicin—bone cancer	6.87e-05	0.000758	CcSEcCtD
Clomipramine—Dysgeusia—Doxorubicin—bone cancer	6.86e-05	0.000756	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	6.84e-05	0.000754	CcSEcCtD
Clomipramine—Malaise—Epirubicin—bone cancer	6.83e-05	0.000752	CcSEcCtD
Clomipramine—Discomfort—Methotrexate—bone cancer	6.8e-05	0.00075	CcSEcCtD
Clomipramine—Nervousness—Doxorubicin—bone cancer	6.8e-05	0.00075	CcSEcCtD
Clomipramine—Vertigo—Epirubicin—bone cancer	6.8e-05	0.00075	CcSEcCtD
Clomipramine—Syncope—Epirubicin—bone cancer	6.79e-05	0.000748	CcSEcCtD
Clomipramine—Leukopenia—Epirubicin—bone cancer	6.77e-05	0.000747	CcSEcCtD
Clomipramine—Back pain—Doxorubicin—bone cancer	6.77e-05	0.000747	CcSEcCtD
Clomipramine—Muscle spasms—Doxorubicin—bone cancer	6.73e-05	0.000742	CcSEcCtD
Clomipramine—Palpitations—Epirubicin—bone cancer	6.69e-05	0.000737	CcSEcCtD
Clomipramine—Confusional state—Methotrexate—bone cancer	6.66e-05	0.000734	CcSEcCtD
Clomipramine—Loss of consciousness—Epirubicin—bone cancer	6.65e-05	0.000733	CcSEcCtD
Clomipramine—Cough—Epirubicin—bone cancer	6.6e-05	0.000728	CcSEcCtD
Clomipramine—Anaphylactic shock—Methotrexate—bone cancer	6.6e-05	0.000728	CcSEcCtD
Clomipramine—Vision blurred—Doxorubicin—bone cancer	6.6e-05	0.000728	CcSEcCtD
Clomipramine—Convulsion—Epirubicin—bone cancer	6.56e-05	0.000723	CcSEcCtD
Clomipramine—Hypertension—Epirubicin—bone cancer	6.53e-05	0.00072	CcSEcCtD
Clomipramine—Chlorpromazine—CYP3A4—bone cancer	6.52e-05	0.0328	CrCbGaD
Clomipramine—Ill-defined disorder—Doxorubicin—bone cancer	6.5e-05	0.000716	CcSEcCtD
Clomipramine—Imipramine—CYP3A4—bone cancer	6.49e-05	0.0326	CrCbGaD
Clomipramine—Nervous system disorder—Methotrexate—bone cancer	6.47e-05	0.000714	CcSEcCtD
Clomipramine—Anaemia—Doxorubicin—bone cancer	6.47e-05	0.000714	CcSEcCtD
Clomipramine—Thrombocytopenia—Methotrexate—bone cancer	6.46e-05	0.000712	CcSEcCtD
Clomipramine—Amitriptyline—CYP3A4—bone cancer	6.45e-05	0.0324	CrCbGaD
Clomipramine—Myalgia—Epirubicin—bone cancer	6.44e-05	0.00071	CcSEcCtD
Clomipramine—Chest pain—Epirubicin—bone cancer	6.44e-05	0.00071	CcSEcCtD
Clomipramine—Arthralgia—Epirubicin—bone cancer	6.44e-05	0.00071	CcSEcCtD
Clomipramine—Agitation—Doxorubicin—bone cancer	6.44e-05	0.000709	CcSEcCtD
Clomipramine—Anxiety—Epirubicin—bone cancer	6.42e-05	0.000708	CcSEcCtD
Clomipramine—Skin disorder—Methotrexate—bone cancer	6.41e-05	0.000707	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	6.4e-05	0.000705	CcSEcCtD
Clomipramine—Hyperhidrosis—Methotrexate—bone cancer	6.38e-05	0.000703	CcSEcCtD
Clomipramine—Discomfort—Epirubicin—bone cancer	6.37e-05	0.000702	CcSEcCtD
Clomipramine—Malaise—Doxorubicin—bone cancer	6.32e-05	0.000696	CcSEcCtD
Clomipramine—Dry mouth—Epirubicin—bone cancer	6.3e-05	0.000695	CcSEcCtD
Clomipramine—Vertigo—Doxorubicin—bone cancer	6.29e-05	0.000694	CcSEcCtD
Clomipramine—Anorexia—Methotrexate—bone cancer	6.29e-05	0.000694	CcSEcCtD
Clomipramine—Syncope—Doxorubicin—bone cancer	6.28e-05	0.000692	CcSEcCtD
Clomipramine—Leukopenia—Doxorubicin—bone cancer	6.27e-05	0.000691	CcSEcCtD
Clomipramine—Confusional state—Epirubicin—bone cancer	6.23e-05	0.000687	CcSEcCtD
Clomipramine—Palpitations—Doxorubicin—bone cancer	6.19e-05	0.000682	CcSEcCtD
Clomipramine—Anaphylactic shock—Epirubicin—bone cancer	6.18e-05	0.000681	CcSEcCtD
Clomipramine—Oedema—Epirubicin—bone cancer	6.18e-05	0.000681	CcSEcCtD
Clomipramine—Hypotension—Methotrexate—bone cancer	6.17e-05	0.00068	CcSEcCtD
Clomipramine—Loss of consciousness—Doxorubicin—bone cancer	6.15e-05	0.000679	CcSEcCtD
Clomipramine—Cough—Doxorubicin—bone cancer	6.11e-05	0.000674	CcSEcCtD
Clomipramine—Shock—Epirubicin—bone cancer	6.08e-05	0.00067	CcSEcCtD
Clomipramine—Convulsion—Doxorubicin—bone cancer	6.07e-05	0.000669	CcSEcCtD
Clomipramine—Nervous system disorder—Epirubicin—bone cancer	6.06e-05	0.000668	CcSEcCtD
Clomipramine—Thrombocytopenia—Epirubicin—bone cancer	6.05e-05	0.000667	CcSEcCtD
Clomipramine—Hypertension—Doxorubicin—bone cancer	6.05e-05	0.000667	CcSEcCtD
Clomipramine—Tachycardia—Epirubicin—bone cancer	6.03e-05	0.000665	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Methotrexate—bone cancer	6.01e-05	0.000663	CcSEcCtD
Clomipramine—Skin disorder—Epirubicin—bone cancer	6e-05	0.000661	CcSEcCtD
Clomipramine—Hyperhidrosis—Epirubicin—bone cancer	5.97e-05	0.000658	CcSEcCtD
Clomipramine—Insomnia—Methotrexate—bone cancer	5.97e-05	0.000658	CcSEcCtD
Clomipramine—Chest pain—Doxorubicin—bone cancer	5.96e-05	0.000657	CcSEcCtD
Clomipramine—Myalgia—Doxorubicin—bone cancer	5.96e-05	0.000657	CcSEcCtD
Clomipramine—Arthralgia—Doxorubicin—bone cancer	5.96e-05	0.000657	CcSEcCtD
Clomipramine—Anxiety—Doxorubicin—bone cancer	5.94e-05	0.000655	CcSEcCtD
Clomipramine—Paraesthesia—Methotrexate—bone cancer	5.93e-05	0.000653	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	5.92e-05	0.000653	CcSEcCtD
Clomipramine—Discomfort—Doxorubicin—bone cancer	5.89e-05	0.000649	CcSEcCtD
Clomipramine—Anorexia—Epirubicin—bone cancer	5.89e-05	0.000649	CcSEcCtD
Clomipramine—Dyspnoea—Methotrexate—bone cancer	5.88e-05	0.000649	CcSEcCtD
Clomipramine—Somnolence—Methotrexate—bone cancer	5.87e-05	0.000647	CcSEcCtD
Clomipramine—Dry mouth—Doxorubicin—bone cancer	5.83e-05	0.000643	CcSEcCtD
Clomipramine—Dyspepsia—Methotrexate—bone cancer	5.81e-05	0.00064	CcSEcCtD
Clomipramine—Hypotension—Epirubicin—bone cancer	5.77e-05	0.000636	CcSEcCtD
Clomipramine—Confusional state—Doxorubicin—bone cancer	5.76e-05	0.000635	CcSEcCtD
Clomipramine—Decreased appetite—Methotrexate—bone cancer	5.74e-05	0.000633	CcSEcCtD
Clomipramine—Anaphylactic shock—Doxorubicin—bone cancer	5.72e-05	0.00063	CcSEcCtD
Clomipramine—Oedema—Doxorubicin—bone cancer	5.72e-05	0.00063	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Methotrexate—bone cancer	5.7e-05	0.000628	CcSEcCtD
Clomipramine—Fatigue—Methotrexate—bone cancer	5.69e-05	0.000627	CcSEcCtD
Clomipramine—Pain—Methotrexate—bone cancer	5.64e-05	0.000622	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Epirubicin—bone cancer	5.63e-05	0.00062	CcSEcCtD
Clomipramine—Shock—Doxorubicin—bone cancer	5.62e-05	0.00062	CcSEcCtD
Clomipramine—Nervous system disorder—Doxorubicin—bone cancer	5.6e-05	0.000618	CcSEcCtD
Clomipramine—Thrombocytopenia—Doxorubicin—bone cancer	5.6e-05	0.000617	CcSEcCtD
Clomipramine—Insomnia—Epirubicin—bone cancer	5.59e-05	0.000616	CcSEcCtD
Clomipramine—Tachycardia—Doxorubicin—bone cancer	5.58e-05	0.000615	CcSEcCtD
Clomipramine—Skin disorder—Doxorubicin—bone cancer	5.55e-05	0.000612	CcSEcCtD
Clomipramine—Paraesthesia—Epirubicin—bone cancer	5.55e-05	0.000611	CcSEcCtD
Clomipramine—Hyperhidrosis—Doxorubicin—bone cancer	5.53e-05	0.000609	CcSEcCtD
Clomipramine—Dyspnoea—Epirubicin—bone cancer	5.51e-05	0.000607	CcSEcCtD
Clomipramine—Somnolence—Epirubicin—bone cancer	5.49e-05	0.000605	CcSEcCtD
Clomipramine—Anorexia—Doxorubicin—bone cancer	5.45e-05	0.000601	CcSEcCtD
Clomipramine—Feeling abnormal—Methotrexate—bone cancer	5.44e-05	0.0006	CcSEcCtD
Clomipramine—Dyspepsia—Epirubicin—bone cancer	5.44e-05	0.000599	CcSEcCtD
Clomipramine—Gastrointestinal pain—Methotrexate—bone cancer	5.4e-05	0.000595	CcSEcCtD
Clomipramine—Decreased appetite—Epirubicin—bone cancer	5.37e-05	0.000592	CcSEcCtD
Clomipramine—Hypotension—Doxorubicin—bone cancer	5.34e-05	0.000589	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Epirubicin—bone cancer	5.33e-05	0.000588	CcSEcCtD
Clomipramine—Fatigue—Epirubicin—bone cancer	5.33e-05	0.000587	CcSEcCtD
Clomipramine—Pain—Epirubicin—bone cancer	5.28e-05	0.000582	CcSEcCtD
Clomipramine—Constipation—Epirubicin—bone cancer	5.28e-05	0.000582	CcSEcCtD
Clomipramine—Urticaria—Methotrexate—bone cancer	5.24e-05	0.000578	CcSEcCtD
Clomipramine—Abdominal pain—Methotrexate—bone cancer	5.22e-05	0.000575	CcSEcCtD
Clomipramine—Body temperature increased—Methotrexate—bone cancer	5.22e-05	0.000575	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Doxorubicin—bone cancer	5.21e-05	0.000574	CcSEcCtD
Clomipramine—Insomnia—Doxorubicin—bone cancer	5.17e-05	0.00057	CcSEcCtD
Clomipramine—Paraesthesia—Doxorubicin—bone cancer	5.13e-05	0.000566	CcSEcCtD
Clomipramine—Dyspnoea—Doxorubicin—bone cancer	5.1e-05	0.000562	CcSEcCtD
Clomipramine—Feeling abnormal—Epirubicin—bone cancer	5.09e-05	0.000561	CcSEcCtD
Clomipramine—Somnolence—Doxorubicin—bone cancer	5.08e-05	0.00056	CcSEcCtD
Clomipramine—Gastrointestinal pain—Epirubicin—bone cancer	5.05e-05	0.000557	CcSEcCtD
Clomipramine—Dyspepsia—Doxorubicin—bone cancer	5.03e-05	0.000555	CcSEcCtD
Clomipramine—Decreased appetite—Doxorubicin—bone cancer	4.97e-05	0.000548	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Doxorubicin—bone cancer	4.93e-05	0.000544	CcSEcCtD
Clomipramine—Fatigue—Doxorubicin—bone cancer	4.93e-05	0.000543	CcSEcCtD
Clomipramine—Urticaria—Epirubicin—bone cancer	4.91e-05	0.000541	CcSEcCtD
Clomipramine—Constipation—Doxorubicin—bone cancer	4.89e-05	0.000539	CcSEcCtD
Clomipramine—Pain—Doxorubicin—bone cancer	4.89e-05	0.000539	CcSEcCtD
Clomipramine—Abdominal pain—Epirubicin—bone cancer	4.88e-05	0.000538	CcSEcCtD
Clomipramine—Body temperature increased—Epirubicin—bone cancer	4.88e-05	0.000538	CcSEcCtD
Clomipramine—Hypersensitivity—Methotrexate—bone cancer	4.86e-05	0.000536	CcSEcCtD
Clomipramine—Asthenia—Methotrexate—bone cancer	4.74e-05	0.000522	CcSEcCtD
Clomipramine—Feeling abnormal—Doxorubicin—bone cancer	4.71e-05	0.000519	CcSEcCtD
Clomipramine—Gastrointestinal pain—Doxorubicin—bone cancer	4.67e-05	0.000515	CcSEcCtD
Clomipramine—Pruritus—Methotrexate—bone cancer	4.67e-05	0.000515	CcSEcCtD
Clomipramine—Hypersensitivity—Epirubicin—bone cancer	4.55e-05	0.000502	CcSEcCtD
Clomipramine—Urticaria—Doxorubicin—bone cancer	4.54e-05	0.000501	CcSEcCtD
Clomipramine—Abdominal pain—Doxorubicin—bone cancer	4.52e-05	0.000498	CcSEcCtD
Clomipramine—Body temperature increased—Doxorubicin—bone cancer	4.52e-05	0.000498	CcSEcCtD
Clomipramine—Diarrhoea—Methotrexate—bone cancer	4.52e-05	0.000498	CcSEcCtD
Clomipramine—Asthenia—Epirubicin—bone cancer	4.43e-05	0.000489	CcSEcCtD
Clomipramine—Pruritus—Epirubicin—bone cancer	4.37e-05	0.000482	CcSEcCtD
Clomipramine—Dizziness—Methotrexate—bone cancer	4.36e-05	0.000481	CcSEcCtD
Clomipramine—Diarrhoea—Epirubicin—bone cancer	4.23e-05	0.000466	CcSEcCtD
Clomipramine—Hypersensitivity—Doxorubicin—bone cancer	4.21e-05	0.000464	CcSEcCtD
Clomipramine—Vomiting—Methotrexate—bone cancer	4.2e-05	0.000463	CcSEcCtD
Clomipramine—Rash—Methotrexate—bone cancer	4.16e-05	0.000459	CcSEcCtD
Clomipramine—Dermatitis—Methotrexate—bone cancer	4.16e-05	0.000458	CcSEcCtD
Clomipramine—Headache—Methotrexate—bone cancer	4.13e-05	0.000456	CcSEcCtD
Clomipramine—Asthenia—Doxorubicin—bone cancer	4.1e-05	0.000452	CcSEcCtD
Clomipramine—Dizziness—Epirubicin—bone cancer	4.08e-05	0.00045	CcSEcCtD
Clomipramine—Pruritus—Doxorubicin—bone cancer	4.04e-05	0.000446	CcSEcCtD
Clomipramine—Vomiting—Epirubicin—bone cancer	3.93e-05	0.000433	CcSEcCtD
Clomipramine—Nausea—Methotrexate—bone cancer	3.92e-05	0.000432	CcSEcCtD
Clomipramine—Diarrhoea—Doxorubicin—bone cancer	3.91e-05	0.000431	CcSEcCtD
Clomipramine—Rash—Epirubicin—bone cancer	3.89e-05	0.000429	CcSEcCtD
Clomipramine—Dermatitis—Epirubicin—bone cancer	3.89e-05	0.000429	CcSEcCtD
Clomipramine—Headache—Epirubicin—bone cancer	3.87e-05	0.000427	CcSEcCtD
Clomipramine—Dizziness—Doxorubicin—bone cancer	3.78e-05	0.000417	CcSEcCtD
Clomipramine—Nausea—Epirubicin—bone cancer	3.67e-05	0.000404	CcSEcCtD
Clomipramine—Vomiting—Doxorubicin—bone cancer	3.63e-05	0.000401	CcSEcCtD
Clomipramine—Rash—Doxorubicin—bone cancer	3.6e-05	0.000397	CcSEcCtD
Clomipramine—Dermatitis—Doxorubicin—bone cancer	3.6e-05	0.000397	CcSEcCtD
Clomipramine—Headache—Doxorubicin—bone cancer	3.58e-05	0.000395	CcSEcCtD
Clomipramine—Nausea—Doxorubicin—bone cancer	3.39e-05	0.000374	CcSEcCtD
Clomipramine—GSTP1—Metabolism—DHFR—bone cancer	2.68e-05	0.00137	CbGpPWpGaD
Clomipramine—CYP2C19—Biological oxidations—GSTP1—bone cancer	2.68e-05	0.00137	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.67e-05	0.00137	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—RGS1—bone cancer	2.67e-05	0.00137	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—GRM4—bone cancer	2.67e-05	0.00137	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NDUFA12—bone cancer	2.65e-05	0.00136	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—GNA11—bone cancer	2.64e-05	0.00136	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	2.64e-05	0.00136	CbGpPWpGaD
Clomipramine—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	2.64e-05	0.00136	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—IL3—bone cancer	2.64e-05	0.00135	CbGpPWpGaD
Clomipramine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	2.63e-05	0.00135	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—GRM4—bone cancer	2.56e-05	0.00131	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—RGS1—bone cancer	2.56e-05	0.00131	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—GRM1—bone cancer	2.55e-05	0.00131	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—SMO—bone cancer	2.51e-05	0.00129	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—GNA11—bone cancer	2.5e-05	0.00128	CbGpPWpGaD
Clomipramine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	2.49e-05	0.00128	CbGpPWpGaD
Clomipramine—GSTP1—Cellular responses to stress—TP53—bone cancer	2.48e-05	0.00127	CbGpPWpGaD
Clomipramine—CYP2D6—Biological oxidations—GSTP1—bone cancer	2.46e-05	0.00126	CbGpPWpGaD
Clomipramine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	2.44e-05	0.00125	CbGpPWpGaD
Clomipramine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	2.43e-05	0.00125	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—GRM1—bone cancer	2.42e-05	0.00124	CbGpPWpGaD
Clomipramine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	2.41e-05	0.00123	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—IL3—bone cancer	2.4e-05	0.00123	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	2.35e-05	0.00121	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.34e-05	0.0012	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—GRM4—bone cancer	2.33e-05	0.00119	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—RGS1—bone cancer	2.33e-05	0.00119	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—GRM4—bone cancer	2.32e-05	0.00119	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—RGS1—bone cancer	2.32e-05	0.00119	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—GRM1—bone cancer	2.32e-05	0.00119	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.31e-05	0.00118	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—CYP3A4—bone cancer	2.27e-05	0.00116	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—SPARC—bone cancer	2.25e-05	0.00115	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—GNA11—bone cancer	2.23e-05	0.00115	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—SMO—bone cancer	2.22e-05	0.00114	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—GRM1—bone cancer	2.22e-05	0.00114	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	2.2e-05	0.00113	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	2.2e-05	0.00113	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NT5C3A—bone cancer	2.19e-05	0.00113	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—GRM4—bone cancer	2.14e-05	0.0011	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RGS1—bone cancer	2.14e-05	0.0011	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—RGS1—bone cancer	2.11e-05	0.00108	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—GRM4—bone cancer	2.11e-05	0.00108	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—JUN—bone cancer	2.1e-05	0.00108	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NDUFA12—bone cancer	2.09e-05	0.00107	CbGpPWpGaD
Clomipramine—CYP1A2—Biological oxidations—GSTP1—bone cancer	2.09e-05	0.00107	CbGpPWpGaD
Clomipramine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	2.06e-05	0.00106	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—GNA11—bone cancer	2.06e-05	0.00106	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—GNA11—bone cancer	2.04e-05	0.00105	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—GNA11—bone cancer	2.03e-05	0.00104	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—IL3—bone cancer	2.02e-05	0.00104	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—SMO—bone cancer	2.02e-05	0.00104	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.02e-05	0.00104	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—GRM1—bone cancer	2.02e-05	0.00103	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—GRM1—bone cancer	2.01e-05	0.00103	CbGpPWpGaD
Clomipramine—ALB—Folate Metabolism—TP53—bone cancer	1.98e-05	0.00102	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RGS1—bone cancer	1.96e-05	0.001	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—GRM4—bone cancer	1.96e-05	0.001	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—TP53—bone cancer	1.88e-05	0.000964	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NDUFA12—bone cancer	1.88e-05	0.000963	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—IL3—bone cancer	1.86e-05	0.000957	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—GRM1—bone cancer	1.86e-05	0.000954	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—GNA11—bone cancer	1.85e-05	0.00095	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—IL3—bone cancer	1.85e-05	0.000948	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL3—bone cancer	1.84e-05	0.000944	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NDUFA12—bone cancer	1.83e-05	0.00094	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—GRM1—bone cancer	1.83e-05	0.00094	CbGpPWpGaD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	1.82e-05	0.000935	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—SPARC—bone cancer	1.77e-05	0.00091	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	1.74e-05	0.000894	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NT5C3A—bone cancer	1.73e-05	0.000889	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NDUFA12—bone cancer	1.73e-05	0.000886	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—SMO—bone cancer	1.71e-05	0.000876	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—GRM1—bone cancer	1.7e-05	0.000871	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL3—bone cancer	1.68e-05	0.000861	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—GNA11—bone cancer	1.64e-05	0.000844	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—SMO—bone cancer	1.63e-05	0.000838	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—GNA11—bone cancer	1.62e-05	0.000833	CbGpPWpGaD
Clomipramine—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.61e-05	0.000826	CbGpPWpGaD
Clomipramine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.59e-05	0.000815	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—GRM4—bone cancer	1.58e-05	0.00081	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RGS1—bone cancer	1.58e-05	0.00081	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—GNA11—bone cancer	1.56e-05	0.000802	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NT5C3A—bone cancer	1.55e-05	0.000798	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NT5C3A—bone cancer	1.52e-05	0.000779	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—GNA11—bone cancer	1.49e-05	0.000766	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—IL3—bone cancer	1.49e-05	0.000765	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IL3—bone cancer	1.47e-05	0.000755	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	1.47e-05	0.000754	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NDUFA12—bone cancer	1.46e-05	0.00075	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—ATF1—bone cancer	1.45e-05	0.000745	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NT5C3A—bone cancer	1.43e-05	0.000734	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—GNA11—bone cancer	1.43e-05	0.000733	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—SMO—bone cancer	1.42e-05	0.000728	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL3—bone cancer	1.42e-05	0.000727	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GRM4—bone cancer	1.37e-05	0.000704	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RGS1—bone cancer	1.37e-05	0.000704	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—GRM1—bone cancer	1.37e-05	0.000703	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL3—bone cancer	1.35e-05	0.000695	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SMO—bone cancer	1.31e-05	0.000672	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	1.3e-05	0.000667	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—GNA11—bone cancer	1.3e-05	0.000666	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—IL3—bone cancer	1.29e-05	0.000664	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.29e-05	0.000663	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—SMO—bone cancer	1.29e-05	0.000662	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	1.28e-05	0.000655	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GRM4—bone cancer	1.25e-05	0.00064	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RGS1—bone cancer	1.25e-05	0.00064	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.24e-05	0.000639	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—PLAU—bone cancer	1.22e-05	0.000627	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NT5C3A—bone cancer	1.21e-05	0.000622	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TGFBR2—bone cancer	1.21e-05	0.000622	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—GNA11—bone cancer	1.2e-05	0.000615	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SMO—bone cancer	1.2e-05	0.000614	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GRM1—bone cancer	1.19e-05	0.00061	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—GNA11—bone cancer	1.18e-05	0.000606	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—IL3—bone cancer	1.18e-05	0.000605	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL3—bone cancer	1.18e-05	0.000603	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IGF1R—bone cancer	1.14e-05	0.000585	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NDUFA12—bone cancer	1.13e-05	0.000579	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.12e-05	0.000576	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ATF1—bone cancer	1.11e-05	0.000572	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—GNA11—bone cancer	1.09e-05	0.000561	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL3—bone cancer	1.09e-05	0.000557	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GRM1—bone cancer	1.08e-05	0.000555	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL3—bone cancer	1.07e-05	0.000549	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ATF1—bone cancer	1.02e-05	0.000522	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PTGS2—bone cancer	1.01e-05	0.000516	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL3—bone cancer	9.91e-06	0.000509	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—PLAU—bone cancer	9.65e-06	0.000495	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SMO—bone cancer	9.65e-06	0.000495	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ENO2—bone cancer	9.61e-06	0.000493	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NT5C3A—bone cancer	9.35e-06	0.00048	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TGFBR2—bone cancer	9.29e-06	0.000477	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—DHFR—bone cancer	8.92e-06	0.000458	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	8.83e-06	0.000453	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—GNA11—bone cancer	8.82e-06	0.000453	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IGF1R—bone cancer	8.74e-06	0.000449	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TGFBR2—bone cancer	8.48e-06	0.000435	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SMO—bone cancer	8.38e-06	0.00043	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GNA11—bone cancer	8.33e-06	0.000428	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—KIT—bone cancer	8.26e-06	0.000424	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ATF1—bone cancer	8.2e-06	0.000421	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL3—bone cancer	8e-06	0.00041	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IGF1R—bone cancer	7.98e-06	0.000409	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—BRAF—bone cancer	7.77e-06	0.000399	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GNA11—bone cancer	7.66e-06	0.000393	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SMO—bone cancer	7.62e-06	0.000391	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ENO2—bone cancer	7.59e-06	0.000389	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYP3A4—bone cancer	7.56e-06	0.000388	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—EGFR—bone cancer	7.53e-06	0.000386	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	7.41e-06	0.00038	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ATF1—bone cancer	7.12e-06	0.000366	CbGpPWpGaD
Clomipramine—ALB—Metabolism—DHFR—bone cancer	7.04e-06	0.000361	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GNA11—bone cancer	6.97e-06	0.000358	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL3—bone cancer	6.94e-06	0.000356	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	6.84e-06	0.000351	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ENO2—bone cancer	6.81e-06	0.00035	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ENO2—bone cancer	6.65e-06	0.000341	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GNA11—bone cancer	6.58e-06	0.000338	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MDM2—bone cancer	6.51e-06	0.000334	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ATF1—bone cancer	6.48e-06	0.000333	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GSTP1—bone cancer	6.46e-06	0.000332	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IGF1R—bone cancer	6.44e-06	0.00033	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KIT—bone cancer	6.34e-06	0.000325	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL3—bone cancer	6.32e-06	0.000324	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—DHFR—bone cancer	6.32e-06	0.000324	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ENO2—bone cancer	6.26e-06	0.000321	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—DHFR—bone cancer	6.17e-06	0.000317	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP3A4—bone cancer	5.96e-06	0.000306	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—BRAF—bone cancer	5.96e-06	0.000306	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	5.94e-06	0.000305	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.93e-06	0.000305	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GNA11—bone cancer	5.9e-06	0.000303	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—DHFR—bone cancer	5.81e-06	0.000298	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KIT—bone cancer	5.79e-06	0.000297	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—EGFR—bone cancer	5.77e-06	0.000296	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GNA11—bone cancer	5.76e-06	0.000296	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—JUN—bone cancer	5.66e-06	0.00029	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1R—bone cancer	5.59e-06	0.000287	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MMP9—bone cancer	5.5e-06	0.000282	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—BRAF—bone cancer	5.44e-06	0.000279	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GNA11—bone cancer	5.43e-06	0.000279	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	5.4e-06	0.000277	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP3A4—bone cancer	5.35e-06	0.000275	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.33e-06	0.000273	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ENO2—bone cancer	5.31e-06	0.000272	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—EGFR—bone cancer	5.27e-06	0.000271	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP3A4—bone cancer	5.23e-06	0.000268	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GSTP1—bone cancer	5.1e-06	0.000262	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	5.08e-06	0.000261	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MDM2—bone cancer	4.99e-06	0.000256	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP3A4—bone cancer	4.92e-06	0.000253	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—DHFR—bone cancer	4.92e-06	0.000253	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—bone cancer	4.91e-06	0.000252	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KIT—bone cancer	4.67e-06	0.00024	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GNA11—bone cancer	4.6e-06	0.000236	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTP1—bone cancer	4.58e-06	0.000235	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MDM2—bone cancer	4.56e-06	0.000234	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTP1—bone cancer	4.47e-06	0.000229	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—EGFR—bone cancer	4.45e-06	0.000228	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—BRAF—bone cancer	4.39e-06	0.000225	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—JUN—bone cancer	4.34e-06	0.000223	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—EGFR—bone cancer	4.25e-06	0.000218	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MMP9—bone cancer	4.22e-06	0.000217	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTP1—bone cancer	4.21e-06	0.000216	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP3A4—bone cancer	4.17e-06	0.000214	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.15e-06	0.000213	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ENO2—bone cancer	4.1e-06	0.00021	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KIT—bone cancer	4.05e-06	0.000208	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—JUN—bone cancer	3.96e-06	0.000203	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—bone cancer	3.88e-06	0.000199	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MMP9—bone cancer	3.85e-06	0.000198	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—BRAF—bone cancer	3.81e-06	0.000196	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—DHFR—bone cancer	3.8e-06	0.000195	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—bone cancer	3.73e-06	0.000192	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EGFR—bone cancer	3.69e-06	0.00019	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KIT—bone cancer	3.69e-06	0.000189	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MDM2—bone cancer	3.68e-06	0.000189	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTP1—bone cancer	3.57e-06	0.000183	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GNA11—bone cancer	3.55e-06	0.000182	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—BRAF—bone cancer	3.47e-06	0.000178	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EGFR—bone cancer	3.41e-06	0.000175	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	3.36e-06	0.000172	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—bone cancer	3.35e-06	0.000172	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—JUN—bone cancer	3.2e-06	0.000164	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MDM2—bone cancer	3.19e-06	0.000164	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EGFR—bone cancer	3.11e-06	0.00016	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MMP9—bone cancer	3.11e-06	0.00016	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MDM2—bone cancer	2.9e-06	0.000149	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—bone cancer	2.86e-06	0.000147	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—JUN—bone cancer	2.77e-06	0.000142	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTP1—bone cancer	2.75e-06	0.000141	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MMP9—bone cancer	2.7e-06	0.000139	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—bone cancer	2.64e-06	0.000136	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—bone cancer	2.61e-06	0.000134	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—JUN—bone cancer	2.52e-06	0.00013	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EGFR—bone cancer	2.51e-06	0.000129	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MMP9—bone cancer	2.46e-06	0.000126	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—bone cancer	2.37e-06	0.000122	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—bone cancer	2.32e-06	0.000119	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—bone cancer	2.18e-06	0.000112	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGFR—bone cancer	2.18e-06	0.000112	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—bone cancer	2.11e-06	0.000108	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGFR—bone cancer	1.98e-06	0.000102	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—bone cancer	1.85e-06	9.49e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—bone cancer	1.83e-06	9.4e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—bone cancer	1.67e-06	8.55e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—bone cancer	1.43e-06	7.32e-05	CbGpPWpGaD
